text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 85650-52-8 | Product Number: M2151


Purity: >98.0%(HPLC)
  • 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
1   ≥20 
10   18  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).

Product Number M2151
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__7H__1__9N__3 = 265.36  
Physical State (20 deg.C) Solid
CAS RN 85650-52-8
Reaxys Registry Number 549345
PubChem Substance ID 125307817
SDBS (AIST Spectral DB) 52906
MDL Number


Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 95.0 %
Melting point 119.0 to 123.0 °C
Properties (reference)
Melting Point 121 °C
Related Laws:
EC Number 288-060-6
RTECS# UQ4410250
Transport Information:
HS Number 2933998090
Mirtazapine: A Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)

Mirtazapine (Org 3770) is the first noradrenergic and specific serotonergic antidepressant (NaSSA). Studies have suggested that mirtazapine acts as an antagonist at central presynaptic α2 adrenergic inhibitory autoreceptors and heteroreceptors, as well as by blocking 5-HT2 and 5-HT3 receptors. Therefore, these antagonisms enhance the release of noradrenaline and 5-HT1A-mediated serotonergic transmission in brain. Mirtazapine is mainly metabolized by CYP1A2, CYP2D6, and CYP3A4. (The product is for research purpose only.)


PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents